new blog post - luminex, page-186

"Only 2 Aussie Biotech companies received Commercialisation Australia grants in 2013

AHZ - Admedus

and

ADO - Anteo Diagnostics

Both of these grants were in excess of $1.5m

Commercialisation Australia does extreme dilligence by contacting testing companies partners etc etc

They know these companies are likely to realise commercial gains and create employment for Aussie Biotech

These 2 companies are the real deal long term"

From the biotech thread.
Agree 100%
Much as I enjoy 'devils advocate' posts and the sometimes outraged responses received :), often after moderation, some comments are best left on the day trader forum at best. If a companies performance thus far and it's prospects are rubbish then why not sell out at 18c/17.5c yesterday and move on? Unless yr selling at a loss at even those prices , but even so...best to get out at a loss and into something more profitable huh? Looks like ADO is a poor investment to some. I'll sell u (some of) mine when they are $5..until then..no.